Merck KGaA (FRA: MRK) was downgraded by equities researchers at Bryan Garnier & Cie to a “neutral” rating in a report issued on Friday. They currently have a $120.78 (€93) target price on the stock.

Shares of Merck KGaA traded up 3.54% during mid-day trading on Friday, hitting €106.50. Merck KGaA has a 52 week low of €72.00 and a 52 week high of €103.00.

Several other analysts have also recently commented on the stock. Analysts at JPMorgan Chase reiterated a “neutral” rating on shares of Merck KGaA in a research note to investors on Thursday. They now have a $125.97 price target on the stock. Separately, analysts at Independent Research GmbH reiterated a “sell” rating on shares of Merck KGaA in a research note to investors on Wednesday. They now have a $123.68 price target on the stock. Finally, analysts at AlphaValue reiterated a “sell” rating on shares of Merck KGaA in a research note to investors on Thursday, November 29th. They now have a $113.64 price target on the stock.

.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.